Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the Vitamin D receptor gene can cause hair loss similar to mutations in the Hairless gene.

A specific DNA pattern in Malassezia restricta may be linked to hair loss in men.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Targeting NETs may help reduce fibrosis in Crohn's disease.

AVT is highly conserved and may have antimicrobial properties.

Tridax procumbens parts have antioxidant properties.

Oxytocin receptor changes in hair cells may help identify autism, especially in males.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Activating TRPV3 stops human hair growth.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

MRI can effectively image skin structures noninvasively.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Finasteride has different absorption and metabolism in male and female rats, with higher concentrations in certain organs and mostly excreted through feces.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Tridax procumbens may be a safe, affordable treatment for some health issues.

Ayurvedic treatments like bloodletting, herbal packs, and medicated liquid flow over the head are a safe and effective alternative for hair loss.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Trichostasis spinulosa is a rare skin condition with hair-filled plugs in hair follicles.

The R343H mutation in the VDR gene causes vitamin D-resistant rickets with alopecia by impairing specific gene activity.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.